Sign In
Buy BBH
$205.55
-2.46 (-1.18%)
At Close: Jul 31, 2026
Can Biotech ETFs Gain On Mixed Q4 Earnings Results?
12:00am, Tuesday, 11'th Feb 2020
Stocks Analysis by Zacks Investment Research covering: Gilead Sciences Inc, Amgen Inc, Biogen Inc, Alexion Pharmaceuticals Inc. Read Zacks Investment Research's latest article on Investing.com
Should Investors Avoid U.S. Healthcare Stocks In An Election Year?
02:35pm, Monday, 10'th Feb 2020
US healthcare is always a political hot potato, and volatility is expected to rise as the November elections approach. The US healthcare sector traded at a pric
Aspiriant LLC Sells 485 Shares of VanEck Vectors Biotech ETF (NASDAQ:BBH)
10:20am, Tuesday, 28'th Jan 2020
Aspiriant LLC cut its holdings in shares of VanEck Vectors Biotech ETF (NASDAQ:BBH) by 7.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exch
Head to Head Comparison: VanEck Vectors Biotech ETF (NASDAQ:BBH) & WhiteHorse Finance (NASDAQ:WHF)
06:04am, Tuesday, 28'th Jan 2020
VanEck Vectors Biotech ETF (NASDAQ:BBH) and WhiteHorse Finance (NASDAQ:WHF) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the str
Adding Biotech ETFs to Your Portfolio
12:17am, Monday, 27'th Jan 2020
Biotech ETFs are among the most popular investment vehicles. Here are some reasons for why they're worth considering.
Biotech ETFs Brush Off Political Attacks on Drug Prices
04:13pm, Tuesday, 21'st Jan 2020
This is another election year and one of the presidential variety, meaning investors and voters can expect to hear plenty about politicians’ efforts to lower drug costs. For now, biotech ETFs, such
EQRx's Challenge, And My Challenge To Them
01:15pm, Thursday, 16'th Jan 2020
EQRx's plan is apparently to come up with new competing pharmaceuticals in existing categories and sell them for lower prices than the patented ones. Insurance
Cypress Capital Group Purchases New Holdings in VanEck Vectors Biotech ETF (NASDAQ:BBH)
09:40am, Sunday, 12'th Jan 2020
Cypress Capital Group acquired a new stake in shares of VanEck Vectors Biotech ETF (NASDAQ:BBH) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Ex
VanEck Vectors Biotech ETF (NASDAQ:BBH) Stock Price Up 0.1%
12:22pm, Friday, 10'th Jan 2020
VanEck Vectors Biotech ETF (NASDAQ:BBH) shares rose 0.1% during trading on Wednesday . The stock traded as high as $139.68 and last traded at $139.42, approximately 7,400 shares were traded during mid
Top ETF Areas for 2020
04:26pm, Wednesday, 25'th Dec 2019
As ETF investing constantly climbs the popularity charts, we highlight a few good ETF areas that investors can bank on for 2020.
Expect More From Biotech ETFs in 2020
04:06pm, Friday, 20'th Dec 2019
Biotechnology ETFs, including the VanEck Vectors Biotech ETF (BBH), were laggards for much of 2019, but that scenario rapidly changed at the start of the fourth quarter. Since the start of the current
Deal or No Deal: Healthcare ETFs to Make a Sweep in 2020
01:33pm, Tuesday, 10'th Dec 2019
While all eyes are on the fate of the phase one trade deal between the United States and China, Healthcare sector can forget tension and soar higher in 2020 even if there is no deal.
Is Trade Scaring You? ETF Strategies for 2019 Holiday Season
06:00pm, Friday, 06'th Dec 2019
It is less likely that Santa alone will drive Wall Street this season as trade tensions persist. Overall, these ETF investing trends should stay strong.
